April 23, 2014 10:32 PM ET

Biotechnology

Company Overview of Kite Pharma, Inc.

Executive Profile

Antoni Ribas M.D., Ph.D.

Special Advisor for Clinical Research and Development and Member of Scientific Advisory Board, Kite Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
----

Background

Dr. Antoni Ribas, M.D., PhD serves as a Special Advisor for Clinical Research and Development at Kite Pharma, Inc. Dr. Ribas serves as an Associate Director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center, Director of the Cell and Gene Therapy Core Facility, and training faculty at the Broad Stem Cell Research Center at UCLA. Dr. Ribas serves as Professor of Medicine, Hematology/Oncology, Surgical Oncology and Director of the Cell and Gene ...

Corporate Headquarters

10924 Le Conte Avenue
Los Angeles, California 90024

United States

Phone: 310-824-9999
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

Post-Doctoral Training
University of California-Los Angeles
Unknown/Other Education
Universitat de Barcelona

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kite Pharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.